| Hafner V, Jäger M, Matthée AK, et al.
Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity. [JOURNAL ARTICLE]
Clin Pharmacol Ther 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Cheng C, Wang X, Weakley SM, et al.
Soybean Isoflavonoid Equol Blocks Ritonavir-Induced Endothelial Dysfunction in Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial Cells. [JOURNAL ARTICLE]
J Nutr 2009 Nov 18.
Abstract | Full Citation | Find Related Articles |
| Stellbrink HJ
Raltegravir in the management of HIV-infected patients. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:281-288.
Abstract | Full Citation |
| Meynard JL, Morand-Joubert L, Lacombe K, et al.
Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Nov 17.
Abstract | Full Citation |
| Eholié SP, Ouiminga M, Ehui E, et al.
Avascular osteonecrosis of the femoral head in three West African HIV-infected adults with heterozygous sickle cell disease. [Journal Article]
Antivir Ther 2009; 14(7):1011-4.
Abstract | Full Citation |
| van der Lugt J, Lange J, Avihingsanon A, et al.
Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals. [Journal Article]
Antivir Ther 2009; 14(7):1001-4.
Abstract | Full Citation |
| Rathbun CR, Liedtke MD, Blevins SM, et al.
Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir. [Journal Article]
HIV Clin Trials 2009 Sep-Oct; 10(5):328-36.
Abstract | Full Citation | Find Related Articles |
| Marseille E, Kahn JG, Pitter C, et al.
The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. [Journal Article]
Appl Health Econ Health Policy 2009; 7(4):229-43.
Abstract | Full Citation |
| van Vonderen MG, Blümer RM, Hassink EA, et al.
Insulin Sensitivity in Multiple Pathways is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Nov 4.
Abstract | Full Citation |
| Stöhr W, Back D, Dunn D, et al.
Factors influencing lopinavir and atazanavir plasma concentration. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Nov 6.
Abstract | Full Citation |
  |
